Dapagliflozin Acutely Improves Endothelial Dysfunction, Reduces Aortic Stiffness and Renal Resistive Index in Type 2 Diabetic Patients: A Pilot Study

Cardiovascular Diabetology - United Kingdom
doi 10.1186/s12933-017-0621-8

Related search